Labor Department Drops Appeal of Overtime Rule Critics Say Could Have Cost Workers Thousands in Pay
New York employment attorney says Biden-era regulation risked stripping overtime eligibility from millions of employees
New York, NY (FreePR.org) -- The U.S. Department of Labor has withdrawn its appeal of a federal court decision blocking a controversial Biden-era overtime rule, ending a legal fight over a policy critics argued would have reduced overtime pay opportunities for workers nationwide.
The rule, blocked by a U.S. District Court in late 2024, would have raised the salary threshold for exempt white-collar employees from $35,568 to $58,656 annually. Supporters said the change would expand worker protections, but opponents argued it would have had the opposite effect for many employees by reclassifying workers into exempt categories that could eliminate overtime pay eligibility.
Employment attorney Steven Mitchell Sack, known as “The Employee’s LawyerⓇ,” said the Labor Department’s decision to abandon the appeal represents a major victory for workers concerned about losing overtime income.
“This rule was promoted as helping employees, but, in practice, it could have prevented many workers from earning overtime altogether,” said Sack. “For countless employees, overtime pay is essential income used to cover rent, groceries, childcare, and savings. The court recognized the Department of Labor exceeded its authority, and dropping the appeal avoids further harm to workers.”
The litigation centered on whether the Department of Labor had the authority under the Fair Labor Standards Act to automatically increase salary thresholds every three years. The New Civil Liberties Alliance argued the rule violated both the Administrative Procedure Act and federal labor law.
A second federal court later vacated the rule entirely, though the federal government initially appealed before pausing the case for further review. The Department of Labor has now formally ended that appeal.
Sack said the decision highlights growing scrutiny over federal labor regulations that may produce unintended economic consequences for employees and employers alike.
“Workers deserve policies that increase earning opportunities — not regulations that risk taking money out of their pockets,” Sack added.
For more information, call (917) 371-8000 or visit www.theemployeeslawyer.com.
###
About Steven Mitchell Sack
Steven Mitchell Sack, "The Employee's Lawyer®," has been enforcing the workplace rights of employees, executives, and sales representatives for more than 46 years. He is a practicing labor and employment attorney, author of 20 books, a lecturer, syndicated radio talk show host, and host of the podcast "Know Your Job Rights with Attorney Steven Sack." With attorney Scott A. Lucas, he obtained a $6.2 million jury verdict in 2015 on behalf of three pregnant employees and a favorable New York Court of Appeals decision for a group of waiters who were denied their fair share of tips that a caterer withheld. For more information, visit www.theemployeeslawyer.com.
###
Contact Information:
Hank Russell, PRMG
(631) 310-5268
hrussell@theprmg.com
Sponsor Message
Thousands of Americans rely on Canadian pharmacies for budget-friendly access to vital medications like Lipitor and Crestor for cholesterol control, or Nexium for managing acid reflux and GERD. Patients living with chronic conditions rely on Humalog and Lantus for diabetes management, and on Advair Diskus and Ventolin inhalers for respiratory issues like asthma and COPD. Millions depend on Zoloft, Prozac, and Abilify for mental health, while Eliquis, Plavix, and Xarelto address heart-related risks. Frequently purchased medications include Celebrex for pain relief and Synthroid for thyroid hormone therapy. Additionally, medications like Viagra and Cialis offer solutions for erectile dysfunction, and drugs like Januvia help manage Type 2 diabetes. Wakefulness-promoting drugs such as Provigil and Nuvigil are invaluable for people with narcolepsy or severe daytime sleepiness. Canadian pharmacies provide U.S. patients with cost-effective options like Cymbalta for nerve pain and Aricept for Alzheimer's, ensuring access to vital medications.
